Susquehanna Fundamental Investments’s Praxis Precision Medicines PRAX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,150	Closed	-$50.4K	–	824
2023 Q1	$50.4K	Hold	4,150	–	–	﹤0.01%	924
2022 Q4	$148K	Sell	4,150 -717	-15%	-$22.4K	﹤0.01%	1095
2022 Q3	$166K	Buy	+4,867	New	+$243K	﹤0.01%	1285
2022 Q1	$168K	Sell	1,097 -127	-10%	-$26.1K	﹤0.01%	1397
2021 Q4	$362K	Buy	+1,224	New	+$359K	0.01%	1056

Other funds holding PRAX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TLP

Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Susquehanna Fundamental Investments's PRAX Position: Q2 2023 in Review

Susquehanna Fundamental Investments sold out of Praxis Precision Medicines (PRAX) in Q2 2023, closing a stake of 4,150 shares — an estimated $50.4K sold.

Susquehanna Fundamental Investments first reported a position in PRAX in Q4 2021 and held it in 5 quarters. The position peaked at $362K in Q4 2021. 78 funds tracked by Wall St. Rank hold PRAX as of Q2 2023.

Susquehanna Fundamental Investments reported no remaining Praxis Precision Medicines position as of Q2 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 4,150 Praxis Precision Medicines shares in Q2 2023, an estimated $50.4K.
Susquehanna Fundamental Investments first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 5 quarters.
Susquehanna Fundamental Investments's Praxis Precision Medicines position peaked at $362K in Q4 2021.
78 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2023, filed 11 Aug 2023.